Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis
出版年份 2009 全文链接
标题
Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis
作者
关键词
-
出版物
EXPERT OPINION ON EMERGING DRUGS
Volume 14, Issue 1, Pages 43-65
出版商
Informa Healthcare
发表日期
2009-02-28
DOI
10.1517/14728210902736568
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Role of the endocannabinoid system in metabolic control
- (2009) Jun Wang et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Orlistat-Associated Adverse Effects and Drug Interactions
- (2009) Theodosios D Filippatos et al. DRUG SAFETY
- Effect of rimonabant on blood pressure in overweight/obese patients with/without co-morbidities: analysis of pooled RIO study results
- (2009) Luis M Ruilope et al. JOURNAL OF HYPERTENSION
- Blocking cannabinoid CB1 receptors for the treatment of nicotine dependence: insights from pre-clinical and clinical studies
- (2008) Bernard Le Foll et al. ADDICTION BIOLOGY
- The Discovery of Taranabant, a Selective Cannabinoid‐1 Receptor Inverse Agonist for the Treatment of Obesity
- (2008) William K. Hagmann ARCHIV DER PHARMAZIE
- The Acyclic CB1R Inverse Agonist Taranabant Mediates Weight Loss by Increasing Energy Expenditure and Decreasing Caloric Intake
- (2008) Carol Addy et al. Cell Metabolism
- Ligand-Binding Architecture of Human CB2 Cannabinoid Receptor: Evidence for Receptor Subtype-Specific Binding Motif and Modeling GPCR Activation
- (2008) Ying Pei et al. CHEMISTRY & BIOLOGY
- Rimonabant: New data and emerging experience
- (2008) Suzanne M. Wright et al. Current Atherosclerosis Reports
- Endocannabinoid system overactivity and the metabolic syndrome: Prospects for treatment
- (2008) Jennifer M. Perkins et al. Current Diabetes Reports
- Endocannabinoid system in food intake and metabolic regulation
- (2008) David Jesudason et al. CURRENT OPINION IN LIPIDOLOGY
- CB1 Cannabinoid Antagonists: Structure-Activity Relationships and Potential Therapeutic Applications
- (2008) Nadine Jagerovic et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Overview of the Chemical Families of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase Inhibitors
- (2008) Severine Vandevoorde CURRENT TOPICS IN MEDICINAL CHEMISTRY
- The Role of Adipocyte Insulin Resistance in the Pathogenesis of Obesity-Related Elevations in Endocannabinoids
- (2008) T. M. D'Eon et al. DIABETES
- Neurophysiological Pathways to Obesity: Below Awareness and Beyond Individual Control
- (2008) D. A. Cohen DIABETES
- Peripheral, but Not Central, CB1 Antagonism Provides Food Intake-Independent Metabolic Benefits in Diet-Induced Obese Rats
- (2008) R. Nogueiras et al. DIABETES
- SERENADE: The Study Evaluating Rimonabant Efficacy in Drug-Naive Diabetic Patients: Effects of monotherapy with rimonabant, the first selective CB1 receptor antagonist, on glycemic control, body weight, and lipid profile in drug-naive type 2 diabetes
- (2008) J. Rosenstock et al. DIABETES CARE
- Treatment Modalities of Obesity: What fits whom?
- (2008) V. Hainer et al. DIABETES CARE
- Efficacy and Safety of Rimonabant for Improvement of Multiple Cardiometabolic Risk Factors in Overweight/Obese Patients: Pooled 1-year data from the Rimonabant in Obesity (RIO) program
- (2008) L. Van Gaal et al. DIABETES CARE
- The endocannabinoid system in obesity and type 2 diabetes
- (2008) V. Di Marzo DIABETOLOGIA
- The cardiometabolic drug rimonabant: after 2 years of RIO-Europe and STRADIVARIUS
- (2008) U. Kintscher EUROPEAN HEART JOURNAL
- Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study †
- (2008) Luc F. Van Gaal et al. EUROPEAN HEART JOURNAL
- Surgical treatment of obesity
- (2008) Mariëlle J F Bult et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Pharmacological evaluation of LH-21, a newly discovered molecule that binds to cannabinoid CB1 receptor
- (2008) Richard Z. Chen et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Sibutramine: current status as an anti-obesity drug and its future perspectives
- (2008) Bikash Sharma et al. EXPERT OPINION ON PHARMACOTHERAPY
- Is rimonabant efficacious and safe in the treatment of obesity?
- (2008) Sheila A Doggrell EXPERT OPINION ON PHARMACOTHERAPY
- Endocannabinoid receptor 1 gene variations increase risk for obesity and modulate body mass index in European populations
- (2008) Michael Benzinou et al. HUMAN MOLECULAR GENETICS
- Modulation of the Endocannabinoid System in Cardiovascular Disease
- (2008) Pál Pacher et al. HYPERTENSION
- Effect of Rimonabant on Progression of Atherosclerosis in Patients With Abdominal Obesity and Coronary Artery Disease
- (2008) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Hope and Fear of Rimonabant
- (2008) John S. Rumsfeld JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Constitutive Activity of the Cannabinoid CB1 Receptor Regulates the Function of Co-expressed Mu Opioid Receptors
- (2008) Meritxell Canals et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Endocannabinoids and the Control of Energy Homeostasis
- (2008) George Kunos et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice
- (2008) Douglas Osei-Hyiaman et al. JOURNAL OF CLINICAL INVESTIGATION
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Properties of Taranabant, a Novel Selective Cannabinoid-1 Receptor Inverse Agonist, for the Treatment of Obesity: Results From a Double-Blind, Placebo-Controlled, Single Oral Dose Study in Health
- (2008) Carol Addy et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Multiple-Dose Pharmacokinetics, Pharmacodynamics, and Safety of Taranabant, a Novel Selective Cannabinoid-1 Receptor Inverse Agonist, in Healthy Male Volunteers
- (2008) Carol Addy et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Cannabinoid Receptor 1 Blocker Rimonabant (SR 141716) for Treatment of Alcohol Dependence
- (2008) Michael Soyka et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- The epidemiology of obesity: the size of the problem
- (2008) W. P. T. James JOURNAL OF INTERNAL MEDICINE
- Endocannabinoids: Some Like it Fat (and Sweet Too)
- (2008) I. Matias et al. JOURNAL OF NEUROENDOCRINOLOGY
- CB1 Receptor Blockade and its Impact on Cardiometabolic Risk Factors: Overview of the RIO Programme with Rimonabant
- (2008) A. J. Scheen JOURNAL OF NEUROENDOCRINOLOGY
- The Endocannabinoid System and the Control of Glucose Homeostasis
- (2008) R. Nogueiras et al. JOURNAL OF NEUROENDOCRINOLOGY
- Dysregulation of the Endocannabinoid System in Obesity
- (2008) S. Engeli JOURNAL OF NEUROENDOCRINOLOGY
- Cannabinoid Receptors: Where They are and What They do
- (2008) K. Mackie JOURNAL OF NEUROENDOCRINOLOGY
- Endogenous Cannabinoids: Structure and Metabolism
- (2008) T. Bisogno JOURNAL OF NEUROENDOCRINOLOGY
- The Endocannabinoid System and Energy Metabolism
- (2008) L. Bellocchio et al. JOURNAL OF NEUROENDOCRINOLOGY
- Neurobiological mechanisms of cannabinoid addiction
- (2008) L. Fattore et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Signaling via CNS cannabinoid receptors
- (2008) Ken Mackie MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Dysregulation of peripheral endocannabinoid levels in hyperglycemia and obesity: Effect of high fat diets
- (2008) Isabel Matias et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects
- (2008) Jonathan Z Long et al. Nature Chemical Biology
- Decoding endocannabinoid signaling
- (2008) Lawrence J Marnett Nature Chemical Biology
- End of the line for cannabinoid receptor 1 as an anti-obesity target?
- (2008) Dan Jones NATURE REVIEWS DRUG DISCOVERY
- Targeting the endocannabinoid system: to enhance or reduce?
- (2008) Vincenzo Di Marzo NATURE REVIEWS DRUG DISCOVERY
- Are Non-prescription Medications Needed for Weight Control?
- (2008) George A. Bray Obesity
- Endocannabinoid Dysregulation in the Pancreas and Adipose Tissue of Mice Fed With a High-fat Diet
- (2008) Katarzyna M. Starowicz et al. Obesity
- A critical review of the cannabinoid receptor as a drug target for obesity management
- (2008) F. Akbas et al. Obesity Reviews
- Intrinsic effects of AM4113, a putative neutral CB1 receptor selective antagonist, on open-field behaviors in rats
- (2008) T JARBE et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Oral bioavailability of the novel cannabinoid CB1 antagonist AM6527: Effects on food-reinforced behavior and comparisons with AM4113
- (2008) K.S. Sink et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Should peripheral CB1 cannabinoid receptors be selectively targeted for therapeutic gain?
- (2008) George Kunos et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Co-occurring Mental Illness and Health Care Utilization and Expenditures in Adults with Obesity and Chronic Physical Illness
- (2008) Chan Shen et al. Disease management : DM
- Biological specificity of visceral adipose tissue and therapeutic intervention
- (2008) Sebastio Perrini et al. ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
- Critical Role of the Endocannabinoid System in the Regulation of Food Intake and Energy Metabolism, with Phylogenetic, Developmental, and Pathophysiological Implications
- (2008) M. Viveros et al. Endocrine Metabolic & Immune Disorders-Drug Targets
- Bioisosteric replacement of dihydropyrazole of 4S-(−)-3-(4-chlorophenyl)-N-methyl-N′-[(4-chlorophenyl)-sulfonyl]-4-phenyl-4,5-dihydro-1H-pyrazole-1-caboxamidine (SLV-319) a potent CB1 receptor antagonist by imidazole and oxazole
- (2007) Brijesh Kumar Srivastava et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Novel cannabinoid receptors
- (2007) A J Brown BRITISH JOURNAL OF PHARMACOLOGY
- Tuning the endocannabinoid system: allosteric modulators of the CB1 receptor
- (2007) R A Ross BRITISH JOURNAL OF PHARMACOLOGY
- The contribution of cyclooxygenase-2 to endocannabinoid metabolism and action
- (2007) C J Fowler BRITISH JOURNAL OF PHARMACOLOGY
- Sibutramine-associated adverse effects: a practical guide for its safe use
- (2007) M. Florentin et al. Obesity Reviews
- Pharmacotherapeutic targeting of the endocannabinoid signaling system: Drugs for obesity and the metabolic syndrome
- (2007) V. Kiran Vemuri et al. PHYSIOLOGY & BEHAVIOR
- Some effects of CB1 antagonists with inverse agonist and neutral biochemical properties
- (2007) Jack Bergman et al. PHYSIOLOGY & BEHAVIOR
- In vitro pharmacological characterization of AM1241: a protean agonist at the cannabinoid CB2 receptor?
- (2006) B B Yao et al. BRITISH JOURNAL OF PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now